Goldman Sachs’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.13M | Sell |
1,542,602
-40,510
| -3% | -$109K | ﹤0.01% | 2941 |
|
|
2025
Q1 | $2.23M | Sell |
1,583,112
-90,065
| -5% | -$127K | ﹤0.01% | 3293 |
|
|
2024
Q4 | $3.33M | Sell |
1,673,177
-15,417
| -0.9% | -$30.7K | ﹤0.01% | 3150 |
|
|
2024
Q3 | $5.32M | Buy |
1,688,594
+163,877
| +11% | +$516K | ﹤0.01% | 2708 |
|
|
2024
Q2 | $4.82M | Sell |
1,524,717
-15,792
| -1% | -$49.9K | ﹤0.01% | 2635 |
|
|
2024
Q1 | $6.92M | Buy |
1,540,509
+80,995
| +6% | +$364K | ﹤0.01% | 2331 |
|
|
2023
Q4 | $2.42M | Buy |
1,459,514
+406,536
| +39% | +$675K | ﹤0.01% | 3086 |
|
|
2023
Q3 | $945K | Sell |
1,052,978
-84,611
| -7% | -$75.9K | ﹤0.01% | 3565 |
|
|
2023
Q2 | $2.45M | Sell |
1,137,589
-1,216,116
| -52% | -$2.61M | ﹤0.01% | 3068 |
|
|
2023
Q1 | $4.59M | Buy |
2,353,705
+192,349
| +9% | +$375K | ﹤0.01% | 2611 |
|
|
2022
Q4 | $8.3M | Buy |
2,161,356
+2,132,701
| +7,443% | +$8.19M | ﹤0.01% | 2262 |
|
|
2022
Q3 | $138K | Buy |
+28,655
| New | +$138K | ﹤0.01% | 4836 |
|